The purpose of this study is to determine whether arhalofenate is safe and effective when dosed in combination with febuxostat in lowering serum uric acid in patients with gout.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01416402?cond=%22Arthritis%22&lup_s=07/28/2011&lup_d=30
